This is a single-center, randomized, prospective, feasibility and acceptability trial in patients with type 1 diabetes. For six weeks, the intervention group will receive weekly personalized coaching messages for glycemic management based on blood data from continuous glucose monitors and bi-weekly personalized coaching messages for depression management based on depression questionnaires. The control group will remain on their current treatment and will not receive any intervention. The purpose of this trial is to evaluate the feasibility and acceptability of the clinical application of automated, personalized coaching messages for glycemic management and depressive symptom in people with type 1 diabetes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
18
For six weeks, the intervention group will receive weekly personalized coaching messages for glycemic management based on blood data from continuous glucose monitors and bi-weekly personalized coaching messages for depression management based on depression questionnaires.
Samsung Medical Center
Seoul, South Korea
Time In Range
Derived from CGM
Time frame: Week 6
Diabetes treatment satisfaction
DSTQ
Time frame: Week 6
Depressive symptoms
PHQ-9
Time frame: Week 6
Time In Tight Range
Derived from CGM
Time frame: Week 6
Time Above Range
Derived from CGM
Time frame: Week 6
Time Below Range
Derived from CGM
Time frame: Week 6
Coefficient of Variation
Derived from CGM
Time frame: Week 6
Glycemic Management Indicator
Derived from CGM
Time frame: Week 6
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.